Crestline Management, LP Nuvasive Inc Transaction History

Crestline Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.09 - $57.79 $2.52 Million - $3.03 Million	-52,357 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $412,346 - $547,697	-8,738 Reduced 14.3%	52,357 $2.75 Million
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $3.48 Million - $4.14 Million	61,095 New	61,095 $3.66 Million
Q3 2018 Nov 14, 2018	SELL	$52.03 - $71.41 $1.4 Million - $1.92 Million	-26,890 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.15 - $56.68 $1.29 Million - $1.52 Million	26,890 New	26,890 $1.4 Million
Q3 2017 Nov 14, 2017	SELL	$53.54 - $68.0 $964,897 - $1.23 Million	-18,022 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	18,022	18,022 $1.39 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.